Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) Shares Sold by Amundi
Amundi lessened its position in shares of Intra-Cellular Therapies, Inc. (NASDAQ:ITCI – Free Report) by 7.0% during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 2,729 shares of the biopharmaceutical company’s stock after selling 206 shares during the period. Amundi’s holdings […]
Amundi lessened its position in shares of Intra-Cellular Therapies, Inc. (NASDAQ:ITCI – Free Report) by 7.0% during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 2,729 shares of the biopharmaceutical company’s stock after selling 206 shares during the period. Amundi’s holdings […]
